Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引：65

作者：

Morris, Patrick J. ^{[1
]}

Moaddel, Ruin ^{[2
]}

Zanos, Panos ^{[3
]}

Moore, Curtis E. ^{[4
]}

Gould, Todd ^{[3
,5
,6
]}

Zarate, Carlos A., Jr. ^{[7
]}

Thomas, Craig J. ^{[1
]}

机构：

[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA

[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA

[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA

[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA

[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA

来源：

ORGANIC LETTERS | 2017年 / 19卷 / 17期

关键词：

ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;

D O I：

10.1021/acs.orglett.7b02177

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

引用

页码：4572 / 4575

页数：4

共 23 条

[11] Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
Newport, D. Jeffrey
Carpenter, Linda L.
McDonald, William M.
Potash, James B.
Tohen, Mauricio
Nemeroff, Charles B.
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (10) : 950 - 966
[12] SYNTHESIS OF KETAMINE METABOLITES-I AND METABOLITE-II AND SOME ANOMALOUS REACTIONS OF 6-BROMOKETAMINE
PARCELL, RF
SANCHEZ, JP
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1981, 46 (25) : 5055 - 5060
[13] Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15
[14] Ketamine - More mechanisms of action than just NMDA blockade
Sleigh, Jamie
Harvey, Martyn
Voss, Logan
Denny, Bill
[J]. TRENDS IN ANAESTHESIA AND CRITICAL CARE, 2014, 4 (2-3) : 76 - 81
[15] AMINO KETONE REARRANGEMENTS .7. SYNTHESIS OF 2-METHYLAMINO-2-SUBSTITUTED PHENYLCYCLOHEXANONES
STEVENS, CL
THUILLIE.A
TAYLOR, KG
DANIHER, FA
DICKERSO.JP
HANSON, HT
NIELSEN, NA
TIKOTKAR, NA
WEIER, RM
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1966, 31 (08) : 2601 - &
[16] Effects of a ketamine metabolite on synaptic NMDAR function
Suzuki, Kanzo
Nosyreva, Elena
Hunt, Kevin W.
Kavalali, Ege T.
Monteggia, Lisa M.
[J]. NATURE, 2017, 546 (7659) : E1 - E3
[17] Direct Asymmetric Amination of α-Branched Cyclic Ketones Catalyzed by a Chiral Phosphoric Acid
Yang, Xiaoyu
Toste, F. Dean
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3205 - 3208
[18] Zanos P, 2017, NATURE, V546, pE4, DOI 10.1038/nature22085
[19] NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, Panos
Moaddel, Ruin
Morris, Patrick J.
Georgiou, Polymnia
Fischell, Jonathan
Elmer, Greg I.
Alkondon, Manickavasagom
Yuan, Peixiong
Pribut, Heather J.
Singh, Nagendra S.
Dossou, Katina S. S.
Fang, Yuhong
Huang, Xi-Ping
Mayo, Cheryl L.
Wainer, Irving W.
Albuquerque, Edson X.
Thompson, Scott M.
Thomas, Craig J.
Zarate, Carlos A., Jr.
Gould, Todd D.
[J]. NATURE, 2016, 533 (7604) : 481 - +
[20] A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Zarate, Carlos A., Jr.
Singh, Jaskaran B.
Carlson, Paul J.
Brutsche, Nancy E.
Ameli, Rezvan
Luckenbaugh, David A.
Charney, Dennis S.
Manji, Husseini K.
[J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (08) : 856 - 864

← 1 2 3 →